FTSE All-Share
5.018,21
PKT
-8,58
PKT
-0,17
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.07.11 | HSBC overweight | Morgan Stanley | |
05.07.11 | Hays sell | Société Générale Group S.A. (SG) | |
05.07.11 | Intertek hold | Société Générale Group S.A. (SG) | |
04.07.11 | Imperial Brands buy | UBS AG | |
04.07.11 | Marks Spencer sell | ING | |
01.07.11 | Glencore buy | Deutsche Bank AG | |
01.07.11 | Sky buy | Nomura | |
01.07.11 | Marks Spencer hold | Société Générale Group S.A. (SG) | |
01.07.11 | Lloyds Banking Group buy | Nomura | |
01.07.11 | Vodafone Group buy | Citigroup Corp. | |
01.07.11 | Lloyds Banking Group buy | Société Générale Group S.A. (SG) | |
01.07.11 | Lloyds Banking Group hold | UniCredit Research | |
30.06.11 | Glencore buy | Société Générale Group S.A. (SG) | |
30.06.11 | Glencore buy | Société Générale Group S.A. (SG) | |
30.06.11 | AstraZeneca buy | UBS AG | |
30.06.11 | Sky buy | Citigroup Corp. | |
30.06.11 | Glencore buy | Citigroup Corp. | |
05.07.11 | Glencore neutral | Exane-BNP Paribas SA | |
29.06.11 | Glencore outperform | Credit Suisse Group | |
29.06.11 | AstraZeneca buy | Citigroup Corp. | |
29.06.11 | Standard Chartered buy | Nomura | |
29.06.11 | Glencore buy | UBS AG | |
28.06.11 | Standard Chartered halten | Independent Research GmbH | |
28.06.11 | Rio Tinto overweight | HSBC | |
28.06.11 | Diageo buy | UBS AG | |
28.06.11 | Anglo American overweight | HSBC | |
28.06.11 | Glencore neutral | HSBC | |
27.06.11 | AstraZeneca buy | UBS AG | |
27.06.11 | Glencore buy | UBS AG | |
27.06.11 | AstraZeneca overweight | Morgan Stanley | |
27.06.11 | AstraZeneca buy | Citigroup Corp. | |
24.06.11 | Unilever buy | Citigroup Corp. | |
24.06.11 | Barclays halten | Independent Research GmbH | |
22.06.11 | BP buy | UBS AG | |
22.06.11 | AstraZeneca halten | Independent Research GmbH | |
22.06.11 | Vodafone Group overweight | J.P. Morgan Cazenove | |
22.06.11 | Vodafone Group overweight | Morgan Stanley | |
21.06.11 | Rio Tinto buy | Citigroup Corp. | |
20.06.11 | BP buy | UBS AG | |
20.06.11 | AstraZeneca buy | UBS AG |